Swiss Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.15 Cr
as on 02-01-2025
- Paid Up Capital ₹ 1.11 Cr
as on 02-01-2025
- Company Age 37 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.10 Cr
as on 02-01-2025
- Satisfied Charges ₹ 6.79 Cr
as on 02-01-2025
- Revenue 53.62%
(FY 2022)
- Profit 2.61%
(FY 2022)
- Ebitda -24.57%
(FY 2022)
- Net Worth 3.07%
(FY 2022)
- Total Assets -3.43%
(FY 2022)
About Swiss Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.15 Cr and a paid-up capital of Rs 1.11 Cr.
The company currently has active open charges totaling ₹28.10 Cr. The company has closed loans amounting to ₹6.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sharadchandra Shah and Darshan Shah serve as directors at the Company.
- CIN/LLPIN
U24231GJ1987PTC009343
- Company No.
009343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 1987
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Swiss Pharma Pvt Ltd offer?
Swiss Pharma Pvt Ltd offers a wide range of products and services, including Hair Care, Hair Growth for Men.
Who are the key members and board of directors at Swiss Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshan Shah  | Managing Director | 01-Sep-2019 | Current |
| Sharadchandra Shah | Managing Director | 23-Jan-1987 | Current |
Board Members(0)
| Name | Designation | Appointment Date | Status |
|---|
Financial Performance of Swiss Pharma.
Swiss Pharma Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 53.62% increase. The company also saw a slight improvement in profitability, with a 2.61% increase in profit. The company's net worth moved up by a moderate rise of 3.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swiss Pharma?
In 2022, Swiss Pharma had a promoter holding of 98.78% and a public holding of 1.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Swiss Sterile Private LimitedActive 10 years 10 monthsSharadchandra Shah and Darshan Shah are mutual person
- Sapphire Medicare Private LimitedActive 19 years 7 months
Sharadchandra Shah and Darshan Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Sep 2024 | ₹1.70 Cr | Open |
Bank Of India Creation Date: 05 Apr 2021 | ₹6.10 M | Open |
Bank Of India Creation Date: 07 May 1994 | ₹12.89 Cr | Open |
How Many Employees Work at Swiss Pharma?
Swiss Pharma has a workforce of 54 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swiss Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
